Robey R W, Honjo Y, van de Laar A, Miyake K, Regis J T, Litman T, Bates S E
Developmental Therapeutics Department, Medicine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 12N226, 9000 Rockville Pike, Bethesda, MD 20892, USA.
Biochim Biophys Acta. 2001 Jun 6;1512(2):171-82. doi: 10.1016/s0005-2736(01)00308-x.
The fluorescent compounds rhodamine 123, LysoTracker Green DMD-26, mitoxantrone, and BODIPY-prazosin were used with the antagonist fumitremorgin C (FTC) in order to develop functional assays for the half-transporter, MXR/BCRP/ABCP1. A measure of FTC-inhibitable efflux was generated for each compound in a series of MXR-overexpressing drug-selected cell lines and in ten unselected cell lines which were used to determine if the four fluorescent compounds were sensitive enough to detect the low MXR levels found in drug-sensitive cell lines. FTC-inhibitable efflux of mitoxantrone and prazosin was found in four of the ten cell lines, SF295, KM12, NCI-H460, and A549, and low but detectable levels of MXR mRNA were also observed by Northern analysis in these cells. FTC-inhibitable mitoxantrone and prazosin efflux in both selected and unselected cell lines was found to correlate well with MXR levels as determined by Northern blotting, r(2)=0.89 and r(2)=0.70 respectively. In contrast, rhodamine and LysoTracker were not able to reliably detect MXR. Cytotoxicity assays performed on two of the four unselected cell lines confirmed increased sensitivity to mitoxantrone in the presence of FTC. FTC was found to be a specific inhibitor of MXR, with half-maximal inhibition of MXR-associated ATPase activity at 1 microM FTC. Short term selections of the SF295, KM12, NCI-H460 and A549 cell lines in mitoxantrone resulted in a small but measurable increase in MXR by both Northern blot and functional assay. These studies show that flow cytometric measurement of FTC-inhibitable mitoxantrone or prazosin efflux is a sensitive and specific method for measuring the function of the MXR half-transporter in both selected and unselected cell lines.
荧光化合物罗丹明123、溶酶体绿色荧光探针DMD - 26、米托蒽醌和硼二吡咯 - 哌唑嗪与拮抗剂烟曲霉震颤素C(FTC)一起使用,以开发针对半转运体MXR/BCRP/ABCP1的功能测定方法。在一系列过表达MXR的药物筛选细胞系以及十个未筛选细胞系中,针对每种化合物生成了FTC抑制性外排的测量值,这些未筛选细胞系用于确定这四种荧光化合物是否足够敏感,以检测在药物敏感细胞系中发现的低水平MXR。在十个细胞系中的四个,即SF295、KM12、NCI - H460和A549中,发现米托蒽醌和哌唑嗪的FTC抑制性外排,并且通过Northern分析在这些细胞中也观察到了低但可检测水平的MXR mRNA。在选定和未选定的细胞系中,FTC抑制性米托蒽醌和哌唑嗪外排与通过Northern印迹法测定的MXR水平良好相关,r(2)分别为0.89和0.70。相比之下,罗丹明和溶酶体绿色荧光探针无法可靠地检测MXR。对四个未筛选细胞系中的两个进行的细胞毒性测定证实,在存在FTC的情况下,对米托蒽醌的敏感性增加。发现FTC是MXR的特异性抑制剂,在1 microM FTC时对MXR相关的ATP酶活性有半数最大抑制作用。在米托蒽醌中对SF295、KM12、NCI - H460和A549细胞系进行短期筛选,通过Northern印迹法和功能测定法均导致MXR有小但可测量的增加。这些研究表明,通过流式细胞术测量FTC抑制性米托蒽醌或哌唑嗪外排是一种在选定和未选定细胞系中测量MXR半转运体功能的灵敏且特异的方法。